Maneesh Gaddam, MD
Pulmonary Disease · Hazard, KYNPI 1144604505
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $924 of the $1,353 with a category attached, or 68.3%. Olympus Corporation Of The Americas accounts for 71.6% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $1,091, 7.0 times the $156 reported in 2023. That places this record below the midpoint for pulmonary disease clinicians in KY, where the typical reported total is $4,124.
Across 30 payments — averaging $45.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation Of The Americas$969
- Grifols USA, LLC$110
- GSK$95
- Philips North America LLC$56
- Merck$37
- Melinta Therapeutics, LLC$22
- plus $64 from 4 others
What the payments were for
- Travel & lodging$92468%
- Food & beverage$42932%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation Of The Americas | 9 | $969 |
| Grifols USA, LLC | 5 | $110 |
| GSK | 6 | $95 |
| Philips North America LLC | 3 | $56 |
| Merck | 2 | $37 |
| Melinta Therapeutics, LLC | 1 | $22 |
| United Therapeutics Corporation | 1 | $19 |
| Mylan Specialty L.p. | 1 | $16 |
| Sanofi | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
How this compares
$1,353 in reported general payments places this provider in the 25th percentile of 226 pulmonary disease providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Hazard
- Ashley ThompsonHazard$10K
- John McConnellLouisville$864K
- Erica GregonisRichmond$390K
- Firas KouraGeorgetown$350K
- Harold HallerLouisville$340K
- Steven KoenigMorehead$242K
- Samantha BaahLouisville$226K
- Sandra SchuldheiszSomerset$225K
- Karim El-KershLouisville$180K
- Dennis DohertyLexington$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.